Group One Trading’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-500
Closed -$6.12K 8387
2025
Q2
$6.12K Sell
500
-100
-17% -$1.26K ﹤0.01% 6998
2025
Q1
$8.6K Buy
+600
New +$9.37K ﹤0.01% 6358
2024
Q4
Sell
-1,500
Closed -$36K 7246
2024
Q3
$36K Hold
1,500
﹤0.01% 4860
2024
Q2
$29.9K Buy
+1,500
New +$29.2K ﹤0.01% 4926
2024
Q1
Sell
-100
Closed -$2.24K 7032
2023
Q4
$2.24K Hold
100
﹤0.01% 6788
2023
Q3
$2.02K Buy
+100
New +$2.27K ﹤0.01% 7038
2021
Q3
Sell
-100
Closed -$4K 8155
2021
Q2
$4K Buy
+100
New +$4.13K ﹤0.01% 7801
2019
Q2
Sell
-1,900
Closed -$81K 4928
2019
Q1
$81K Buy
+1,900
New +$85.1K ﹤0.01% 3310
2016
Q3
Sell
-200
Closed -$7K 4530
2016
Q2
$7K Buy
+200
New +$6.13K ﹤0.01% 4176
2016
Q1
Sell
-100
Closed -$3K 4548
2015
Q4
$3K Sell
100
-2,200
-96% -$68.4K ﹤0.01% 4460
2015
Q3
$65K Sell
2,300
-6,900
-75% -$241K ﹤0.01% 3358
2015
Q2
$373K Buy
9,200
+900
+11% +$40.4K 0.01% 2032
2015
Q1
$408K Buy
8,300
+7,900
+1,975% +$366K 0.01% 1770
2014
Q4
$18K Buy
+400
New +$15.7K ﹤0.01% 3992

Other funds holding AVNS

Group One Trading's AVNS Position: Q2 2019 in Review

Group One Trading sold out of Avanos Medical (AVNS) in Q2 2019, closing a stake of 1,190 shares — an estimated $51K sold.

Group One Trading first reported a position in AVNS in Q1 2015 and held it in 5 quarters. The position peaked at $251K in Q2 2016. 317 funds tracked by Wall St. Rank hold AVNS as of Q2 2019.

  • Group One Trading reported no remaining Avanos Medical position as of Q2 2019 after selling out during the quarter.
  • Group One Trading sold 1,190 Avanos Medical shares in Q2 2019, an estimated $51K.
  • Group One Trading first reported a position in Avanos Medical in Q1 2015 and held it in 5 quarters.
  • Group One Trading's Avanos Medical position peaked at $251K in Q2 2016.
  • 317 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2019.

Based on Group One Trading's 13F filing for Q2 2019, filed 9 Aug 2019.